KODK

Business Context and Reporting Period

Company: Eastman Kodak Company (KODK)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2024
Business Overview: Kodak is a global manufacturer focused on commercial print and advanced materials and chemicals. The company operates through three reportable segments: Print, Advanced Materials and Chemicals, and Brand.

Key Financial Metrics

Note: Q3 2023 Net Earnings were $2 million, but Diluted EPS was reported as $0.00 due to anti-dilutive securities.

Material Changes vs. Prior Period

• Revenue Decline: Total revenues decreased 3% ($8 million) in Q3 2024 and 8% ($65 million) for the nine months ended September 30, 2024, compared to the prior year. The decline was primarily driven by lower volumes in the Print segment.
• Profitability Improvement: Despite revenue declines, Net Earnings increased significantly to $18 million in Q3 2024 from $2 million in Q3 2023. This was largely due to a $27 million loss on extinguishment of debt recorded in Q3 2023 that did not recur in 2024.
• Segment Performance:
  • Print: Revenues declined 7% in Q3 and 11% year-to-date. Operational EBITDA turned negative at ($9) million for both Q3 and the nine-month period, down from positive $4 million and $18 million respectively in 2023.
  • Advanced Materials and Chemicals: Revenues increased 11% in Q3 and 3% year-to-date, driven by volume and pricing improvements in Industrial Film and Chemicals.
• Cash Flow: Operating cash flow turned negative, using $11 million for the nine months ended September 30, 2024, compared to providing $21 million in the prior year period. This was impacted by the absence of prior-year insurance reimbursements and government refunds.

Guidance, Outlook, Risks, and Unusual Items

• Unusual Items:
  • Inventory Reserve: A $4 million inventory reserve adjustment was recorded in Q3 2024 for the Electrophotographic Printing Solutions (EPS) business due to higher-than-expected volume declines.
  • Debt Extinguishment: Q3 2023 included a $27 million loss on extinguishment of debt, which significantly depressed prior-year earnings.
• Outlook & Strategy: Management expects to return to sustainable positive cash flow through pricing actions, cost reductions, and working capital utilization. Capital expenditures for 2024 are expected to be between $50 million and $60 million.
• Risks & Contingencies:
  • Liquidity & Debt Maturity: The company has $216 million in redeemable convertible preferred stock (Series B and C) maturing in May 2026. If not extended or converted, the maturity of Term Loans could be accelerated to February 2026.
  • Legal Proceedings: Ongoing litigation in Brazil regarding tax matters (accruals of $3 million for claims of $86 million) and shareholder derivative lawsuits regarding the 2020 DFC pharmaceutical loan announcement.
  • Geopolitical: Operations in Russia have ceased; the company is monitoring impacts from conflicts in Ukraine and Israel, though direct exposure is currently deemed immaterial.

Investor Verification Checklist

• Preferred Stock Maturity: Verify the status of the $216 million Series B and C Preferred Stock maturing in May 2026 and the potential acceleration of Term Loan maturities.
• EPS Business Viability: Assess the long-term outlook for the Electrophotographic Printing Solutions business following the $4 million inventory write-down and distributor demand reductions.
• Cash Flow Sustainability: Monitor the trend of operating cash flow, which turned negative in the first nine months of 2024, and the company's ability to fund operations without additional financing.
• Legal Exposure: Review the status of Brazilian tax litigation and the appeal of the dismissed shareholder derivative lawsuit regarding the DFC announcement.
• Collateral Requirements: Confirm the level of restricted cash ($100 million) held as collateral for workers' compensation and letters of credit, and the potential for release of these funds.